GDG meetingDeclaration of Interests
First GDG meeting (13th September 2007)SN declared a personal pecuniary interest; he received honoraria from Leo Pharma for a talk given from in October 2006, and from Sanofi Aventis for a talk given in June 2006. He declared that he knew of no personal family interest. He declared a non-personal pecuniary interest; he is a grant holder (but not administrator/manager) for a study of dalteparin on lung cancer $1,000,000 from Pfizer. He declared that he knew of no personal non-pecuniary interest.
Second GDG Meeting (29th October 2007)SN declared a personal non-pecuniary interest; he has been involved with the Welsh Assembly on a committee to promote safe prevention of VTE in association with Lifeblood. He declared he knew of no other personal pecuniary interest, personal family interest, non-personal pecuniary interest or personal non-pecuniary interest, above those he declared at the previous meeting.
Third GDG Meeting (28th November 2007)No change to declarations
Fourth GDG Meeting (9th January 2008)SN declared a non-personal pecuniary interest; he has accepted and invitation to become a trustee of Lifeblood. He declared that he knew of no personal pecuniary interest, personal family interest or personal non-pecuniary interest.
Fifth GDG Meeting (21st February 2008)No change to declarations
Sixth GDG Meeting (2nd April 2008)No change to declarations
Seventh GDG Meeting (13th May 2008)No change to declarations
Eight GDG Meeting (27th June 2008)Not attended
Ninth GDG Meeting (2nd September 2008)SN declared a personal non-pecuniary interest; he has been invited to be a member of a thromboprophylaxis forum, supported by an unrestricted educational grant from Boerhinger Ingelheim. He declared that he knew of no personal pecuniary interest, personal family interest or non-personal pecuniary interest, above those declared at the previous meeting.
Tenth GDG Meeting (8th October 2008)No change to declarations
Eleventh GDG Meeting (14th November 2008)Not attended
Twelfth GDG Meeting (16th December 2008)No change to declarations
Thirteenth GDG Meeting (18th May 2009)No change to declarations
Fourteenth GDG Meeting (8th July 2009)No change to declarations
Fifteenth GDG meeting (3rd November 2009)Not attended

From: Appendix B, Declarations of interests

Cover of Venous Thromboembolism
Venous Thromboembolism: Reducing the Risk of Venous Thromboembolism (Deep Vein Thrombosis and Pulmonary Embolism) in Patients Admitted to Hospital.
NICE Clinical Guidelines, No. 92.
National Clinical Guideline Centre – Acute and Chronic Conditions (UK).
Copyright © 2010, National Clinical Guideline Centre - Acute and Chronic Conditions.

Apart from any fair dealing for the purposes of research or private study, criticism or review, as permitted under the Copyright, Designs and Patents Act, 1988, no part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.

The use of registered names, trademarks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant laws and regulations and therefore for general use.

The rights of National Clinical Guideline Centre - Acute and Chronic Conditions to be identified as Author of this work have been asserted by them in accordance with the Copyright, Designs and Patents Act, 1988.

PubMed Health. A service of the National Library of Medicine, National Institutes of Health.